News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
693,578 Results
Type
Article (39457)
Company Profile (251)
Press Release (653870)
Section
Business (204118)
Career Advice (2006)
Deals (35420)
Drug Delivery (93)
Drug Development (80999)
Employer Resources (169)
FDA (16147)
Job Trends (14838)
News (345045)
Policy (32497)
Tag
Academia (2537)
Alliances (49368)
Alzheimer's disease (1316)
Approvals (16133)
Artificial intelligence (208)
Bankruptcy (358)
Best Places to Work (11646)
Biotechnology (178)
Breast cancer (230)
Cancer (1766)
Cardiovascular disease (132)
Career advice (1670)
CAR-T (127)
Cell therapy (366)
Clinical research (65353)
Collaboration (687)
Compensation (381)
COVID-19 (2569)
C-suite (171)
Data (1674)
Diabetes (218)
Diagnostics (6299)
Earnings (85628)
Employer resources (145)
Events (111112)
Executive appointments (583)
FDA (17080)
Funding (616)
Gene therapy (251)
GLP-1 (659)
Government (4365)
Healthcare (18787)
Infectious disease (2684)
Interviews (311)
IPO (16470)
Job creations (3628)
Job search strategy (1421)
Layoffs (439)
Legal (7891)
Lung cancer (258)
Manufacturing (241)
Medical device (13274)
Medtech (13279)
Mergers & acquisitions (19336)
Metabolic disorders (566)
Neuroscience (1731)
NextGen: Class of 2025 (6518)
Non-profit (4476)
Northern California (2160)
Obesity (312)
Opinion (197)
Patents (173)
People (56908)
Phase I (20355)
Phase II (28788)
Phase III (21433)
Pipeline (768)
Postmarket research (2562)
Preclinical (8589)
Radiopharmaceuticals (264)
Rare diseases (328)
Real estate (5899)
Regulatory (21971)
Research institute (2314)
Resumes & cover letters (349)
Southern California (1857)
Startups (3574)
United States (19054)
Vaccines (618)
Weight loss (213)
Date
Today (173)
Last 7 days (790)
Last 30 days (2881)
Last 365 days (34551)
2025 (5208)
2024 (35263)
2023 (40112)
2022 (51195)
2021 (55726)
2020 (54095)
2019 (46558)
2018 (35027)
2017 (32115)
2016 (31491)
2015 (37561)
2014 (31334)
2013 (26350)
2012 (28577)
2011 (29276)
2010 (27337)
Location
Africa (718)
Arizona (211)
Asia (37558)
Australia (6151)
California (4931)
Canada (1745)
China (408)
Colorado (225)
Connecticut (234)
Europe (80576)
Florida (725)
Georgia (171)
Illinois (461)
Indiana (268)
Japan (126)
Maryland (756)
Massachusetts (3762)
Michigan (200)
Minnesota (341)
New Jersey (1391)
New York (1414)
North Carolina (851)
Northern California (2160)
Ohio (174)
Pennsylvania (1127)
South America (1095)
Southern California (1857)
Texas (724)
Utah (153)
Washington State (474)
693,578 Results for "avid radiopharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Avidity Biosciences to Participate in Upcoming Investor Conferences
February 25, 2025
·
2 min read
Press Releases
Avid Bioservices, Inc. Provides Notice of Fundamental Change and Make-Whole Fundamental Change to Holders of its Convertible Notes in Connection with Completed Merger
February 6, 2025
·
6 min read
Press Releases
Avid Stockholders Approve Transaction with GHO and Ampersand
January 31, 2025
·
4 min read
Press Releases
Avidity Biosciences Reports Fourth Quarter 2024 Financial Results and Recent Highlights
February 27, 2025
·
13 min read
Biotech Beach
Avidity Biosciences, Inc. Announces Pricing of Public Offering of Common Stock - June 14, 2024
Avidity Biosciences, Inc. announced the pricing of an underwritten public offering of 10,550,000 shares of its common stock at a price to the public of $38.00 per share.
June 13, 2024
·
5 min read
Biotech Beach
Avidity Biosciences, Inc. Announces Proposed Public Offering of Common Stock - June 12, 2024
Avidity Biosciences, Inc., a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, announced that it intends to offer and sell, subject to market and other conditions, $300.0 million of shares of its common stock in an underwritten public offering.
June 12, 2024
·
5 min read
Biotech Beach
Avidity Biosciences to Participate in Upcoming June 2024 Investor Conference
Avidity Biosciences, Inc., a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, announced that Avidity management will be participating at the following upcoming conference.
June 14, 2024
·
1 min read
Press Releases
Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners
February 6, 2025
·
5 min read
Biotech Beach
Avidity Biosciences to Participate in Upcoming May 2024 Investor Conference
Avidity Biosciences, Inc., a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, announced that Avidity management will be participating in the following upcoming conference:
May 8, 2024
·
1 min read
Biotech Beach
Avidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Avidity Biosciences, Inc. announced that it has closed its previously announced underwritten public offering of 12,132,500 shares of its common stock, including 1,582,500 shares sold pursuant to the underwriters’ full exercise of their option to purchase additional shares, at a price to the public of $38.00 per share.
June 17, 2024
·
4 min read
1 of 69,358
Next
